Verona Pharma competitorsClear all

Verona Pharma's top competitors include ReCode Therapeutics, Vaxess Technologies, Univercells and Centrexion.
Verona Pharma
Verona Pharma
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
ReCode Therapeutics
ReCode Therapeutics
ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.
Vaxess Technologies
Vaxess Technologies
Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery.
Univercells
Univercells
We believe making biologics available and affordable for all can only happen by changing the rules. And by bringing out the best of technology innovations.
Centrexion
Centrexion
Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.
Founding Date
Founding Date
N/A
Founding Date
2015
Founding Date
2012
Founding Date
2013
Founding Date
2013
Type
Type
Public
Type
Private
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
London, GB HQ
Cardiff, GB
Raleigh, US
Locations
Menlo Park, US HQ
Dallas, US
Locations
Cambridge, US HQ
Locations
Charleroi, BE HQ
Nivelles, BE
Woluwe Saint Pierre, BE
Locations
Boston, US HQ
Baltimore, US
Employees
Employees
33
Employees
20
Employees
2315% increase
Employees
140
Employees
274% increase
Twitter followers
Twitter followers
N/A
Twitter followers
14
Twitter followers
890
Twitter followers
401
Twitter followers
245
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
11
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
3
Average likes per tweet (last 30 days)
2.5
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
N/A
Alexa Website Rank
N/A
Alexa Website Rank
44594
Alexa Website Rank
61888
Alexa Website Rank
267791

Financial

Net income
Net income
(£19.9m) (FY, 2018)
Net income
N/A
Net income
N/A
Net income
N/A
Net income
($24.7m) (FY, 2017)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
$ 80m (11 months ago)
Latest funding round
$ 8.2m (over 1 year ago)
Latest funding round
$ 18.8m (over 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 11.5m
Total funding raised
$ 82m
Total funding raised
$ 24.4m
Total funding raised
$ 37.7m
Total funding raised
$ 136.1m
For sources of this data, please see the company profile

View company profiles

ReCode Therapeutics
HQ
Menlo Park, US
Employees
20

ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors.

View company
Vaxess Technologies
HQ
Cambridge, US
Employees
23↑ 15% increase

Vaxess is commercializing a proprietary technology that uses a silk-derived protein to stabilize vaccines so they can be stored and shipped without refrigeration and a novel sustained release microneedle for improved vaccine delivery.

View company
Univercells
HQ
Charleroi, BE
Employees
140

We believe making biologics available and affordable for all can only happen by changing the rules. And by bringing out the best of technology innovations.

View company
Centrexion
HQ
Boston, US
Employees
27↑ 4% increase

Centrexion Therapeutics is focused on developing new therapies for moderate to severe chronic pain that address the safety and efficacy gaps in the current treatment paradigm.

View company